Evommune, Inc. (EVMN)
NYSE · Healthcare
Evommune, Inc. Revenue 2024–2025
Evommune, Inc. annual/quarterly revenue history and growth rate from 2024 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Evommune, Inc. revenue for the quarter ending March 31, 2026 was 0, a 100.00% decrease year-over-year.
- Evommune, Inc. annual revenue for 2025 was 13.0 M, a 85.71% increase from 2024.
- Evommune, Inc. annual revenue for 2024 was 7.0 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Evommune, Inc. Revenue — FAQ
Evommune, Inc. (EVMN) revenue over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
What is Evommune, Inc.'s revenue?
Evommune, Inc. (EVMN) reported revenue of $13M for fiscal 2025.
Where can I see EVMN's revenue history?
The chart and table above show Evommune, Inc.'s revenue by year and by quarter, including the growth rate.